OMNICELL, INC. (OMCL) earnings date
Feb 4, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-20
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 4 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 29, 2026 | before open | 29 | 8-K |
| Q2 FY2026 | Thu, Jul 30, 2026 | before open | 30 | 8-K |
| Q1 FY2026 | Tue, Apr 28, 2026 | before open | 28 | 8-K |
| Q4 FY2025 | Thu, Feb 5, 2026 | before open | 36 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | before open | 30 | 8-K |
| Q2 FY2025 | Thu, Jul 31, 2025 | before open | 31 | 8-K |
| Q1 FY2025 | Tue, May 6, 2025 | before open | 36 | 8-K |
| Q4 FY2024 | Thu, Feb 6, 2025 | before open | 37 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 Contact: Omnicell, Inc. David Unger 4220 North Freeway Vice President, Investor Relations Fort Worth, TX 76137 ir@omnicell.com Omnicell Announces Third Quarter 2026 Financial Results Omnicell delivers solid third quarter 2026 financial results Updates full year 2026 guidance FORT WORTH, Texas -- October 29, 2026 -- Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,”" exhibit |
| Q3 FY2026 | "Guided by innovation, the Report highlights the Company’s continuous focus on advancing autonomous medication management while supporting a more sustainable and patient-centered healthcare ecosystem. 2026 Guidance The table below summarizes Omnicell’s fourth quarter and updated full year 2026 guidance." exhibit |
| Q3 FY2026 | "Given our strong third quarter 2026 profitability performance and continued focus on disciplined execution, we are increasing our full year 2026 non-GAAP EBITDA and non-GAAP earnings per share guidance ranges." exhibit |
| Q3 FY2026 | "In addition, as we are through the first three quarters of the year, we are tightening our full year 2026 total, product, and service revenues guidance ranges." exhibit |
| Q3 FY2026 | "We are also tightening our full year 2026 annual recurring revenue guidance range, with the low end unchanged, reflecting our increased visibility into the business as we approach year end." exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 Contact: Omnicell, Inc. David Unger 4220 North Freeway Vice President, Investor Relations Fort Worth, TX 76137 ir@omnicell.com Omnicell Announces Second Quarter 2026 Financial Results Omnicell delivers solid second quarter 2026 financial results Updates full year 2026 guidance FORT WORTH, Texas -- July 30, 2026 -- Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,”" exhibit |
| Q2 FY2026 | "Mandoli will lead the expansion of specialty pharmacy and 340B capabilities focused on strengthening customer value and supporting the Company’s long-term growth strategy. 2026 Guidance The table below summarizes Omnicell’s third quarter and updated full year 2026 guidance." exhibit |
| Q2 FY2026 | "Given our strong second quarter 2026 profitability performance and continued focus on disciplined execution, we are increasing our full year 2026 non-GAAP EBITDA and non-GAAP earnings per share guidance ranges." exhibit |
| Q2 FY2026 | "In addition, as we are through the first half of the year, we are tightening our full year 2026 revenues guidance ranges." exhibit |
| Q2 FY2026 | "We are also updating our product bookings guidance to reflect our current assessment of the range of potential outcomes for full year 2026 and our annual recurring revenue guidance to reflect certain growth opportunities that we now expect will take longer to develop than previously projected." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/OMCL
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/OMCL
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/OMCL/"><img src="https://veritasdata.dev/embed/OMCL.svg" alt="OMCL earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/OMCL/)
Script
<script async src="https://veritasdata.dev/embed/OMCL.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/OMCL"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.